Literature DB >> 16393281

High accuracy and cost-effectiveness of a biopsy-avoiding endoscopic approach in diagnosing coeliac disease.

G Cammarota1, P Cesaro, A Martino, G Zuccalà, R Cianci, E Nista, L M Larocca, F M Vecchio, A Gasbarrini, G Gasbarrini.   

Abstract

BACKGROUND: The 'immersion' technique during upper endoscopy allows the visualization of duodenal villi and the detection of total villous atrophy. AIM: To evaluate the accuracy of the immersion technique in detecting total villous atrophy in suspected coeliac patients. The accuracy in diagnosing coeliac disease and the potential cost-sparing of a biopsy-avoiding approach, based on selection of individuals with coeliac disease-related antibodies and on endoscopic detection of absence of villi, were also analysed.
METHODS: The immersion technique was performed in 79 patients with positive antibodies and in 105 controls. Duodenal villi were evaluated as present or absent. As reference, results were compared with histology. Diagnostic approaches, including endoscopy with or without biopsy, were designed to investigate patients with coeliac disease-related antibodies and total villous atrophy. A cost-minimization analysis was performed.
RESULTS: All patients with positive antibodies had coeliac disease. The sensitivity, specificity, positive and negative predictive values of endoscopy to detect total villous atrophy was always 100%. The sensitivity, specificity, positive and negative predictive values of biopsy-avoiding or biopsy-including strategies in diagnosing coeliac disease when villi were absent was always 100%. The biopsy-avoiding strategy was cost-sparing.
CONCLUSIONS: Upper endoscopy is highly accurate in detecting total villous atrophy coeliac patients. A biopsy-avoiding approach is both accurate and cost-sparing to diagnose coeliac disease in subjects with marked duodenal villous atrophy.

Entities:  

Mesh:

Year:  2006        PMID: 16393281     DOI: 10.1111/j.1365-2036.2006.02732.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

Review 1.  Emerging technologies in upper gastrointestinal endoscopy and celiac disease.

Authors:  Giovanni Cammarota; Paolo Fedeli; Antonio Gasbarrini
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-11

Review 2.  Endoscopic tools for the diagnosis and evaluation of celiac disease.

Authors:  Gianluca Ianiro; Antonio Gasbarrini; Giovanni Cammarota
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

3.  Computer-aided texture analysis combined with experts' knowledge: Improving endoscopic celiac disease diagnosis.

Authors:  Michael Gadermayr; Hubert Kogler; Maximilian Karla; Dorit Merhof; Andreas Uhl; Andreas Vécsei
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

4.  Are ESPGHAN "biopsy-sparing" guidelines for celiac disease also suitable for asymptomatic patients?

Authors:  Chiara Maria Trovato; Monica Montuori; Caterina Anania; Maria Barbato; Anna Rita Vestri; Sofia Guida; Salvatore Oliva; Fabrizio Mainiero; Salvatore Cucchiara; Francesco Valitutti
Journal:  Am J Gastroenterol       Date:  2015-09-15       Impact factor: 10.864

Review 5.  Capsule endoscopy in celiac disease.

Authors:  Cristiano Spada; Maria-Elena Riccioni; Riccardo Urgesi; Guido Costamagna
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

6.  Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease.

Authors:  Anna Chiara Piscaglia; Sergio Rutella; Lucrezia Laterza; Valentina Cesario; Mariachiara Campanale; Immacolata Alessia Cazzato; Gianluca Ianiro; Federico Barbaro; Luca Di Maurizio; Giuseppina Bonanno; Tonia Cenci; Giovanni Cammarota; Luigi Maria Larocca; Antonio Gasbarrini
Journal:  J Transl Med       Date:  2015-07-11       Impact factor: 5.531

Review 7.  Survey on computer aided decision support for diagnosis of celiac disease.

Authors:  Sebastian Hegenbart; Andreas Uhl; Andreas Vécsei
Journal:  Comput Biol Med       Date:  2015-02-23       Impact factor: 4.589

8.  Scale invariant texture descriptors for classifying celiac disease.

Authors:  Sebastian Hegenbart; Andreas Uhl; Andreas Vécsei; Georg Wimmer
Journal:  Med Image Anal       Date:  2013-02-13       Impact factor: 8.545

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.